Sign in to view content

Pharmacokinetic Profile of the Port Delivery System With Ranibizumab in the Phase 3 Archway Trial

John W. Kitchens, MD

Video
Published 2021

Related

Association Between Early Vision-Related Quality of Life (QoL) Outcomes and Anatomic Dryness in neovascular AMD and DME in the VIEW and FAME trials
Michael A. Singer, MD
On Demand Cases, Courses, and Papers
2019
New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases
Alay S. Banker, MD
Annual Meeting Talks
2018
The LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results
Carl C. Awh, MD, FASRS
Updates from the Field
2018

Category: AMD-Neovascular

See more